Found 6 matching trials
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
PHASE2Researchers conducting this study hope to learn about the safety and effect...
Location
University of Chicago Comprehensive Cancer Center
Elimination of Prostate Cancer Treatment Side Effects Using a Nutraceutical
PHASE1Does nutraceutical N-111 lower the number of side effects occurring during ...
Location
Optimal Health Research
Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer
PHASE2The high incidence of prostate cancer is one of the important diseases that...
Clinical Study on Neoadjuvant Therapy of Homoharringtonine Combined With Androgen Deprivation for Prostate Cancer
PHASE2The high incidence of prostate cancer is one of the important diseases that...
Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy
PHASE3Risedronate is an orally administered pyridinyl bisphosphonate that is 36 t...
Location
Center for Urological Research
Neoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy(ADT)for High Risk Prostate Cancer
PHASE2This trial aims to evaluate the efficacy and safety of neoadjuvant therapy ...
Location
The Affiliated Hospital of Nanjing University Medical School